Cargando…
Identifying patient-level risk factors associated with non-β-lactam resistance outcomes in invasive MRSA infections in the United States using chain graphs
BACKGROUND: MRSA is one of the most common causes of hospital- and community-acquired infections. MRSA is resistant to many antibiotics, including β-lactam antibiotics, fluoroquinolones, lincosamides, macrolides, aminoglycosides, tetracyclines and chloramphenicol. OBJECTIVES: To identify patient-lev...
Autores principales: | Love, William J, Wang, C Annie, Lanzas, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252986/ https://www.ncbi.nlm.nih.gov/pubmed/35795242 http://dx.doi.org/10.1093/jacamr/dlac068 |
Ejemplares similares
-
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
por: Gonzales, Patrick R., et al.
Publicado: (2015) -
β-Lactam Resistance and Enterobacteriaceae, United States
por: Whichard, Jean M., et al.
Publicado: (2005) -
1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018) -
Inhibition of WTA Synthesis
Blocks the Cooperative
Action of PBPs and Sensitizes MRSA to β-Lactams
por: Farha, Maya A., et al.
Publicado: (2012) -
Purine Nucleosides Interfere with c-di-AMP Levels and Act as Adjuvants To Re-Sensitize MRSA To β-Lactam Antibiotics
por: Nolan, Aaron C., et al.
Publicado: (2022)